newsfilter
← Latest News
Business Wire·

Faeth Therapeutics to Participate in Upcoming November Investor Conferences

  • Faeth Therapeutics (Nasdaq: FTH) announced management participation in the Guggenheim 3rd Annual Healthcare Innovation Conference on Wednesday, November 11, 2026, in Boston, MA, for 1x1 investor meetings.
  • The company confirmed a presentation at the Jefferies Global Healthcare Conference in London, UK, on Tuesday, November 17, 2026, at 8:30 AM GMT.
  • Live webcasts of the presentations & fireside chats will be available via the Events and Presentations section of the Faeth website at investors.faeththerapeutics.com.
  • Replays of the conference webcasts will be accessible for approximately 90 days following each event.
  • Faeth Therapeutics is a clinical-stage oncology company focused on multi-node inhibition of oncogenic pathways, with its lead program PIKTOR being an all-oral combination of serabelisib & sapanisertib for endometrial & breast cancer.
  • The company was co-founded in 2019 by Anand Parikh, Oliver Maddocks, Ph.D., & scientific founders Lewis Cantley, Ph.D., Siddhartha Mukherjee, M.D., D.Phil., Karen Vousden, Ph.D., Scott Lowe, Ph.D., & Greg Hannon, Ph.D.
  • Investor inquiries can be directed to SVP Investor Relations Matthew Biegler, while media inquiries should be sent to Patrick Schmidt of Consort Partners.